Celltrion Inc., a major South Korean biopharmaceutical firm, said Tuesday its two new biosimilars for bone disease treatment have obtained approval from the United States. The U.S. Food and Drug ...

For patients with a rare genetic disorder that turns their muscles into bone, there is new hope. The disease is […] ...

Since you can’t see your bones aging, you should be proactive about preventing osteoporosis. Atrium Health’s Fracture ...

I was recently diagnosed with Paget’s disease after suffering fatigue symptoms and muscle soreness in my neck, pelvic and ...

A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...

Clinical research has long focused on ways to harness the actions of the immune system. From vaccines to immunotherapies, ...

People living with Paget’s are at increased risk of fractures, so identify and remove any tripping hazards in the home.

Researchers have shown that innate immune training, also known as trained immunity (TRIM), leads to aggravated bone loss in experimental models of periodontitis and inflammatory arthritis.

STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) are approved by FDA for all indications of reference products ...

Fanconi anemia (FA) is a rare genetic disorder impairing bone marrow's blood cell production, leading to severe health issues ...

Young adults are increasingly reporting osteopenia, once considered an elderly bone condition. Poor nutrition, lack of ...